The following is a summary of “Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic ...

A phase 3 trial confirms delgocitinib cream is safe and effective for long-term treatment of chronic hand eczema, maintaining disease control for up to 52 weeks.

Eczema gets worse during the winter, in dusty conditions and when ... But many of them will relapse later in life and in that case often with hand eczema," says Laura von Kobyletzki, a researcher ...

A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic hand eczema achieved a ...

Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...